Literature DB >> 6747691

Ultrastructural alterations in blood vessels of the white matter after experimental spinal cord trauma.

S E Kapadia.   

Abstract

The ultrastructure of the microvasculature of the white matter of the spinal cord was studied after experimentally induced trauma in the cat. Immediately after the induction of trauma, disruption of endothelial cell junctions, increased pinocytotic activity in endothelial cells, and perivascular edema were seen in the blood vessels at the site of injury, but not in those of adjacent segments. However, within 2 hours of injury, the blood vessels of the white matter of the rostral and caudal segments also showed evidence of increased endothelial cell pinocytotic activity and perivascular edema, but disruption of endothelial junctions was not seen. It is therefore concluded that vasogenic edema occurs in the white matter at the site of injury soon after trauma and is due both to leakage from vessels with damaged endothelial cell junctions and also to increased transvesicular transport. By contrast, vasogenic edema develops only after a lapse of time in segments rostral and caudal to the site of injury, and probably results from increased transvesicular transport. A possible role for neurogenic chemical mediators in the genesis of the perivascular edema is discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6747691     DOI: 10.3171/jns.1984.61.3.0539

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

1.  Central spinal cord lesions in stenosis of the cervical canal.

Authors:  J H Faiss; G Schroth; W Grodd; E Koenig; B Will; A Thron
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

2.  Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury.

Authors:  J Marc Simard; Orest Tsymbalyuk; Alexander Ivanov; Svetlana Ivanova; Sergei Bhatta; Zhihua Geng; S Kyoon Woo; Volodymyr Gerzanich
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

3.  Glibenclamide for the treatment of acute CNS injury.

Authors:  David B Kurland; Cigdem Tosun; Adam Pampori; Jason K Karimy; Nicholas M Caffes; Volodymyr Gerzanich; J Marc Simard
Journal:  Pharmaceuticals (Basel)       Date:  2013-10-11

Review 4.  The pathogenesis of multiple sclerosis. Additional considerations.

Authors:  C M Poser
Journal:  J Neurol Sci       Date:  1993-04       Impact factor: 3.181

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.